Research & Innovation

研究開発

The Role of LAT1 in Cancer and the Power of Inhibition Unlocking a New Frontier in Cancer Treatment
At Atransen Pharma, our research focuses on a transformative approach to cancer treatment: targeting LAT1 (L-type Amino Acid Transporter 1). LAT1 is a critical transporter that facilitates the uptake of essential amino acids, which are indispensable for cancer cell growth and survival. By inhibiting LAT1, we aim to disrupt this fundamental process, offering a groundbreaking therapeutic strategy with high specificity and reduced side effects.